Talis Biomedical Corporation (TLIS)
USD 1.6
(6.67%)
USD 1.6
(6.67%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -34.12 USD | 45.36% |
| 2022 | -62.45 USD | 50.49% |
| 2021 | -126.13 USD | 59.84% |
| 2020 | -314.06 USD | -71.73% |
| 2019 | -182.88 USD | -28.92% |
| 2018 | -141.85 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -7.15 USD | 3.38% |
| 2024 Q2 | -4.86 USD | 32.03% |
| 2023 Q4 | -7.40 USD | 14.15% |
| 2023 FY | - USD | 45.36% |
| 2023 Q1 | -9.32 USD | -148.27% |
| 2023 Q2 | -8.27 USD | 11.27% |
| 2023 Q3 | -8.62 USD | -4.23% |
| 2022 Q2 | -15.07 USD | 19.76% |
| 2022 FY | - USD | 50.49% |
| 2022 Q4 | 19.31 USD | 235.79% |
| 2022 Q3 | -14.22 USD | 5.64% |
| 2022 Q1 | -18.78 USD | -15.36% |
| 2021 Q4 | -16.28 USD | 27.16% |
| 2021 Q1 | -69.21 USD | -105.43% |
| 2021 FY | - USD | 59.84% |
| 2021 Q2 | -37.71 USD | 45.51% |
| 2021 Q3 | -22.35 USD | 40.73% |
| 2020 Q3 | -101.53 USD | -193.78% |
| 2020 FY | - USD | -71.73% |
| 2020 Q4 | -33.69 USD | 66.82% |
| 2020 Q2 | -34.56 USD | -36.22% |
| 2020 Q1 | -25.37 USD | 3.43% |
| 2019 FY | - USD | -28.92% |
| 2019 Q4 | -26.27 USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acutus Medical, Inc. | -2.81 USD | -1114.235% |
| Biotricity, Inc. | -1.66 USD | -1955.422% |
| Cell MedX Corp. | -0.00 USD | -6823900.0% |
| Dynatronics Corporation | -1.00 USD | -3312.0% |
| Nemaura Medical Inc. | -0.57 USD | -5885.965% |
| PetVivo Holdings, Inc. | -0.78 USD | -4274.359% |
| RetinalGenix Technologies Inc. | -0.12 USD | -28333.333% |
| Sonendo, Inc. | -0.65 USD | -5149.231% |
| Telesis Bio, Inc. | -1.64 USD | -1980.488% |
| Viveve Medical, Inc. | -2.65 USD | -1187.547% |